BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$69.70
-2.88 (-3.97%)
▼
5d:
+1.69%
30d:
+3.09%
90d:
-9.32%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
BBIO is down 3.4% this week, but smart money is accumulating calls. Top strike: $60 2026-05-15 with 504 OI. Call ratio: 75% View Scanner →
Strength: 4.2/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BBIO trades at premium valuation expecting 375.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BBIO trades at premium valuation expecting 375.3% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $69.70, which is considered extended relative to its 30-day fair value range of $66.27 to $71.97. From a valuation perspective, the stock is trading at a premium (Forward PE: 34850.0) compared to its historical average (324.5). At these levels, the market is pricing in 375.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $67.57, while resistance sits at $73.41. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $100.64 (+44.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $67.57, while resistance sits at $73.41. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: BBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $100.64 (+44.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$66.27 -
$71.97
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 44.4% below Wall St target ($100.64)
- BEARISH: Market expects 375.3% growth - appears too optimistic based on history
Fair Price Analysis
30-Day Fair Range
$66.27 -
$71.97
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$67.57
Resistance Level
$73.41
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34850.00
Wall Street Target
$100.64
(+44.4%)
Revenue Growth (YoY)
2521.2%
Profit Margin
-144.4%
Valuation Premium vs History
+375.3% premium
PE vs Historical
34850.0 vs 324.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+375.3%
(market-implied from PE analysis)
1-Year Target
$104.55
(+50%)
2-Year Target
$156.83
(+125%)
3-Year Target
$235.24
(+238%)
3-Yr Target (if PE normalizes)
(PE: 34850→325)
PE COMPRESSION
$2.19
(-97%)
Significant PE compression expected
Share & Embed Analysis
Last updated: March 30, 2026 7:04 AM ET
Data refreshes hourly during market hours. Next update: 8:04 AM
Data refreshes hourly during market hours. Next update: 8:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-03-12
Andrea Ellis
SELL
64921 shares
2026-03-04
Neil Kumar
SELL
28053 shares
2026-02-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 59 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 47 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
